Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Google has announced that using its newly incorporated Lyria 3 model, Gemini users will be able to generate 30-second music tracks based on a prompt, or remix an existing track to their liking. The ...

Pranay Parab is an independent tech journalist based in Mumbai, India. He covers tech for Lifehacker, and specializes in tutorials and in-depth features. Apple Music is testing a new AI playlist ...

Remember back in 2021 when everyone thought a cartoon monkey was the peak of human financial evolution? Well, we have come a long way since then. If you are reading this in 2026, you already know that ...

Google Docs now offers AI-generated audio summaries through Gemini, allowing users to create multi-minute audio overviews of their documents. PCWorld reports the feature includes customizable playback ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

NFT valuations have slid back to pre-2021 levels as minting expands, sales fall and major platforms exit amid a prolonged market downturn. The global non-fungible token (NFT) sector fell below $1.5 ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...